Search: WFRF:(Seferovic Petar M) >
Heart Failure Assoc...
Heart Failure Association of the European Society of Cardiology update on sodium-glucose co-transporter 2 inhibitors in heart failure (an update on the sodium-glucose co-transporter 2 inhibitors in heart failure: beyond glycaemic control. A position paper of the Heart Failure Association of the European Society of Cardiology)
-
- Seferovic, Petar M. (author)
- Univ Belgrade, Serbia; Serbian Acad Arts & Sci, Serbia
-
- Fragasso, Gabriele (author)
- Univ Hosp San Raffaele, Italy
-
- Petrie, Mark (author)
- Univ Glasgow, Scotland
-
show more...
-
- Mullens, Wilfried (author)
- Hasselt Univ, Belgium; Ziekenhuis Oost, Belgium
-
- Ferrari, Roberto (author)
- Univ Hosp Ferrara, Italy; Univ Hosp Ferrara, Italy; Maria Cecilia Hosp, Italy
-
- Thum, Thomas (author)
- Hannover Med Sch, Germany
-
- Bauersachs, Johann (author)
- Med Sch Hannover, Germany
-
- Anker, Stefan D. (author)
- Berlin Inst Hlth Ctr Regenerat Therapies BCRT, Germany; Charit Univ Med Berlin, Germany
-
- Ray, Robin (author)
- Basildon & Thurrock Univ Hosp NHS Fdn Trust, England
-
- Cavusoglu, Yuksel (author)
- Eskisehir Osmangazi Univ, Turkey
-
- Polovina, Marija (author)
- Univ Belgrade, Serbia; Clin Ctr Serbia, Serbia
-
- Metra, Marco (author)
- Univ Brescia, Italy
-
- Ambrosio, Giuseppe (author)
- Univ Perugia, Italy
-
- Prasad, Krishna (author)
- United Kingdom Med & Healthcare Prod Regulatory A, England
-
- Seferovic, Jelena (author)
- Univ Belgrade, Serbia; Clin Ctr, Serbia
-
- Jhund, Pardeep S. (author)
- Univ Glasgow, Scotland
-
- Dattilo, Giuseppe (author)
- Univ Messina, Italy
-
- Celutkiene, Jelena (author)
- Vilnius Univ, Lithuania
-
- Piepoli, Massimo (author)
- Guglielmo da Saliceto Hosp, Italy
-
- Moura, Brenda (author)
- Univ Porto, Portugal
-
- Chioncel, Ovidiu (author)
- Univ Med & Pharm Carol Davila, Romania; Emergency Inst Cardiovasc Dis Prof CC Iliescu, Romania
-
- Ben Gal, Tuvia (author)
- Tel Aviv Univ, Israel
-
- Heymans, Stephane (author)
- Maastricht Univ, Netherlands
-
- Jaarsma, Tiny (author)
- Linköpings universitet,Avdelningen för omvårdnad och reproduktiv hälsa,Medicinska fakulteten
-
- Hill, Loreena (author)
- Queens Univ Belfast, North Ireland
-
- Lopatin, Yuri (author)
- Volgograd State Med Univ, Russia
-
- Lyon, Alexander R. (author)
- Imperial Coll London, England; Royal Brompton Hosp, England
-
- Ponikowski, Piotr (author)
- Wroclaw Med Univ, Poland
-
- Lainscak, Mitja (author)
- Gen Hosp Murska Sobota, Slovenia; Univ Ljubljana, Slovenia
-
- Jankowska, Ewa (author)
- Wroclaw Med Univ, Poland
-
- Mueller, Christian (author)
- Univ Hosp Basel, Switzerland
-
- Cosentino, Francesco (author)
- Karolinska Inst, Sweden; Karolinska Univ Hosp, Sweden
-
- Lund, Lars H. (author)
- Karolinska Univ Hosp, Sweden; Karolinska Univ Hosp, Sweden
-
- Filippatos, Gerasimos S. (author)
- Natl & Kapodistrian Univ Athens, Greece
-
- Ruschitzka, Frank (author)
- Univ Heart Ctr, Switzerland
-
- Coats, Andrew J. S. (author)
- IRCCS San Raffaele Pisana, Italy
-
- Rosano, Giuseppe M. C. (author)
- IRCCS San Raffaele Pisana, Italy
-
show less...
-
(creator_code:org_t)
- 2020-10-27
- 2020
- English.
-
In: European Journal of Heart Failure. - : WILEY. - 1388-9842 .- 1879-0844. ; 22:11, s. 1984-1986
- Related links:
-
https://onlinelibrar...
-
show more...
-
https://urn.kb.se/re...
-
https://doi.org/10.1...
-
show less...
Abstract
Subject headings
Close
- The Heart Failure Association (HFA) of the European Society of Cardiology (ESC) has recently issued a position paper on the role of sodium-glucose co-transporter 2 (SGLT2) inhibitors in heart failure (HF). The present document provides an update of the position paper, based of new clinical trial evidence. Accordingly, the following recommendations are given: center dot Canagliflozin, dapagliflozin empagliflozin, or ertugliflozin have consistently demonstrated to be effective for the prevention of HF hospitalization in patients with type 2 diabetes mellitus and established cardiovascular disease or at high cardiovascular risk. The specifically listed agents are recommended. center dot Dapagliflozin or empagliflozin are recommended to reduce the combined risk of HF hospitalization and cardiovascular death in symptomatic patients with HF and reduced ejection fraction, already receiving guideline-directed medical therapy, regardless of the presence of type 2 diabetes mellitus.
Subject headings
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Kardiologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Cardiac and Cardiovascular Systems (hsv//eng)
Keyword
- Heart failure; Sodium– glucose co‐ transporter 2 inhibitors; Type 2 diabetes mellitus; Cardiovascular outcomes; Renal function
Publication and Content Type
- ref (subject category)
- art (subject category)
Find in a library
To the university's database
- By the author/editor
-
Seferovic, Petar ...
-
Fragasso, Gabrie ...
-
Petrie, Mark
-
Mullens, Wilfrie ...
-
Ferrari, Roberto
-
Thum, Thomas
-
show more...
-
Bauersachs, Joha ...
-
Anker, Stefan D.
-
Ray, Robin
-
Cavusoglu, Yukse ...
-
Polovina, Marija
-
Metra, Marco
-
Ambrosio, Giusep ...
-
Prasad, Krishna
-
Seferovic, Jelen ...
-
Jhund, Pardeep S ...
-
Dattilo, Giusepp ...
-
Celutkiene, Jele ...
-
Piepoli, Massimo
-
Moura, Brenda
-
Chioncel, Ovidiu
-
Ben Gal, Tuvia
-
Heymans, Stephan ...
-
Jaarsma, Tiny
-
Hill, Loreena
-
Lopatin, Yuri
-
Lyon, Alexander ...
-
Ponikowski, Piot ...
-
Lainscak, Mitja
-
Jankowska, Ewa
-
Mueller, Christi ...
-
Cosentino, Franc ...
-
Lund, Lars H.
-
Filippatos, Gera ...
-
Ruschitzka, Fran ...
-
Coats, Andrew J. ...
-
Rosano, Giuseppe ...
-
show less...
- About the subject
-
- MEDICAL AND HEALTH SCIENCES
-
MEDICAL AND HEAL ...
-
and Clinical Medicin ...
-
and Cardiac and Card ...
- Articles in the publication
-
European Journal ...
- By the university
-
Linköping University